Home › Trial NCT00001338
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
- Trial IDNCT00001338
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment65
- Start date1993-06
- ConditionsBreast Neoplasms · Fever · Hematologic Diseases · Neutropenia · Sepsis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.